The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.

N/ANot Yet RecruitingNCT07761598

Jacobs institute15 enrolled

Overview

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.

The FAST study is an Early Feasibility Study (EFS), prospective, open-label, single-arm, unblinded, fifteen (n=15) patient investigation

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Aneurysm Cerebral

Interventions

Fred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.DEVICE

medial device intervention for aneurysm cerebral.

Eligibility

Sex: ALLMin age: 22 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject has a single untreated target IA. Exclusion Criteria: * Subject with anatomy not appropriate for endovascular treatment.

Locations (1)

The Jacobs Institute

Buffalo, New York, United States

Outcomes

Primary Outcomes

A thromboembolic event in the territory supplied by the treated artery.

Time frame: 12 months

Central Contacts

Carlos Dr. Pena, PhD

CONTACT

(716) 888-4814 cpena@jacobsinstitute.org

Kevin MacDonald

CONTACT

(716) 888-4814 kmacdonald@jacobsinstitute.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.